Published in Infect Immun on March 01, 2000
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32
Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (2000) 1.09
Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun (2008) 1.09
Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun (2000) 1.03
The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. BMC Immunol (2008) 0.99
Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice. PLoS One (2010) 0.98
Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes. Infect Immun (2001) 0.93
Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Infect Immun (2006) 0.90
Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination. Infect Immun (2001) 0.90
Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model. Clin Diagn Lab Immunol (2005) 0.81
Review of the neutrophil response to Bordetella pertussis infection. Pathog Dis (2015) 0.77
Functional diversity of helper T lymphocytes. Nature (1996) 18.09
Generation and analysis of interleukin-4 deficient mice. Science (1991) 8.80
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med (1996) 5.07
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med (1996) 4.86
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun (1993) 3.04
Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med (1991) 2.79
IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol (1990) 2.41
Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology (1995) 2.40
The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol (1989) 2.40
IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today (1997) 2.37
Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun (1993) 2.36
Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun (1997) 2.03
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun (1998) 2.02
A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine (1997) 1.99
Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis (1997) 1.92
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun (1996) 1.61
Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol (2000) 1.56
Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A (1992) 1.48
Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. J Immunol (1995) 1.40
Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol (1993) 1.38
Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes. J Leukoc Biol (1991) 1.29
The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol Lett (1987) 1.23
Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur J Immunol (1998) 1.19
T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J Exp Med (1999) 1.18
Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun (1999) 1.15
Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun (1997) 1.12
Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol (1993) 1.09
Efficacy of pertussis vaccination in England. Report from the PHLS Epidemiological Research Laboratory and 21 area health authorities. Br Med J (Clin Res Ed) (1982) 1.05
Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukoc Biol (1992) 1.04
Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J Exp Med (1993) 0.95
IL-4 is an endogenous inhibitor of neutrophil influx and subsequent pathology in acute antibody-mediated inflammation. J Immunol (1998) 0.91
Production of soluble ICAM-1 from human endothelial cells induced by IL-1 beta and TNF-alpha. Inflammation (1994) 0.90
Cytokine and adhesion molecule requirements for neutrophil recruitment during glycogen-induced peritonitis. Inflamm Res (1998) 0.90
Induction of macrophage inflammatory protein 2 gene expression by interleukin 1 beta in rat lung. Thorax (1995) 0.86
Contrasting effects of proinflammatory and T-helper lymphocyte subset-2 cytokines on the 5-lipoxygenase pathway in monocytes. Kidney Int (1997) 0.85
Induction of inflammatory cytokines in the brain following respiratory infection with Bordetella pertussis. J Neuroimmunol (2000) 0.81
Proinflammatory cytokines in the adverse systemic and neurologic effects associated with parenteral injection of a whole cell pertussis vaccine. Ann N Y Acad Sci (1998) 0.79
Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun (1993) 2.36
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet (1991) 2.10
Long-term ecosystem stress: the effects of years of experimental acidification on a small lake. Science (1985) 2.03
Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis (1997) 1.92
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun (1999) 1.69
Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun (1996) 1.61
Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol (2000) 1.56
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine (2001) 1.49
OAS1: a multiple sclerosis susceptibility gene that influences disease severity. Neurology (2010) 1.45
Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int Immunol (1998) 1.44
Conformational-dependent recognition of influenza virus hemagglutinin by murine T helper clones. Eur J Immunol (1986) 1.37
Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol (2000) 1.32
Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur J Immunol (1998) 1.19
Extensive diversity in the recognition of influenza virus hemagglutinin by murine T helper clones. J Exp Med (1986) 1.18
Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J Infect Dis (2000) 1.17
Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity. J Immunol (2000) 1.16
Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol (2001) 1.14
Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol (2000) 1.12
The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1. Vaccine (1999) 1.06
Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev Biol Stand (1997) 1.05
Fasciola hepatica cathepsin L cysteine proteinase suppresses Bordetella pertussis-specific interferon-gamma production in vivo. Parasite Immunol (2001) 1.03
Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides. J Exp Med (1989) 1.00
Interferon-gamma mediated immune effector mechanisms against Bordetella pertussis. Immunol Lett (1999) 0.99
Biodegradable microparticles for oral immunization. Vaccine (1993) 0.99
Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells. Infect Immun (1999) 0.99
Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. Br J Haematol (1983) 0.97
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. Vaccine (1995) 0.95
Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus. J Gen Virol (1991) 0.94
Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J Gen Virol (2000) 0.94
Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens. J Infect Dis (2000) 0.93
Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones. J Virol (1992) 0.90
Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. AIDS Res Hum Retroviruses (1994) 0.90
Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination. Infect Immun (2001) 0.90
Pertussis infection and vaccination induces Th1 cells. Immunol Today (1998) 0.88
Studies on the immunogenicity of Chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB). Vaccine (1991) 0.88
T-cell subsets in B-chronic lymphocytic leukaemia (CLL) Br J Haematol (1982) 0.87
Suppressor T cells in B-cell chronic lymphocytic leukaemia: relationship to clinical stage. Leuk Res (1982) 0.84
A single amino acid substitution in influenza hemagglutinin abrogates recognition by monoclonal antibody and a spectrum of subtype-specific L3T4+ T cell clones. Eur J Immunol (1987) 0.83
Cellular immunity in pertussis. J Med Microbiol (1993) 0.83
Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Rev (2001) 0.82
Induction of inflammatory cytokines in the brain following respiratory infection with Bordetella pertussis. J Neuroimmunol (2000) 0.81
Interleukin-1beta-dependent changes in the hippocampus following parenteral immunization with a whole cell pertussis vaccine. J Neuroimmunol (2000) 0.80
Suicide selection of murine T helper clones specific for variable regions of the influenza hemagglutinin molecule. Eur J Immunol (1986) 0.80
The treatment of secondary orgasmic dysfunction II. J Sex Marital Ther (1987) 0.79
Preparative separation of foreign antigens for highly efficient presentation to T cells in vitro. J Immunol Methods (1992) 0.79
Approaches to new vaccines. Crit Rev Biotechnol (1998) 0.79
Proinflammatory cytokines in the adverse systemic and neurologic effects associated with parenteral injection of a whole cell pertussis vaccine. Ann N Y Acad Sci (1998) 0.79
Glycerol-induced seizure: involvement of IL-1beta and glutamate. Neuroreport (1999) 0.79
The effects of sex education on women with secondary orgasmic dysfunction. J Sex Marital Ther (1983) 0.79
Normal human B cells express endogenous sheep erythrocyte (E) receptor after appropriate in vitro culture. Eur J Immunol (1983) 0.78
A B-cell proliferation with aberrant true E-rosette formation: a sequential study with a panel of monoclonal antibodies and other surface markers. Scand J Haematol (1983) 0.78
Mechanisms of immunity to the respiratory pathogen Bordetella pertussis in normal and gene knockout mice: clearance of primary infection is not enhanced by therapeutic interleukin-12. Biochem Soc Trans (1997) 0.77
Treatment of secondary orgasmic dysfunction: an outcome study. Arch Sex Behav (1986) 0.77
Immune recognition of influenza virus haemagglutinin. Philos Trans R Soc Lond B Biol Sci (1989) 0.76
The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells. Biochem Soc Trans (1997) 0.76
T cell subpopulations in B cell chronic lymphocytic leukaemias. Clin Exp Immunol (1984) 0.75
The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus. J Gen Virol (1999) 0.75
Bioaccumulation of radionuclides in fertilized Canadian Shield lake basins. Sci Total Environ (1998) 0.75
Group treatment of sexual dysfunctions: a methodological review of the outcome literature. J Sex Marital Ther (1982) 0.75
Heterogeneity in the recognition of the simian immunodeficiency virus envelope glycoprotein by CD4+ T cell clones from immunized macaques. J Immunol (1992) 0.75
Haematological and immune suppressive effects of total body irradiation in the rat. Ir J Med Sci (1980) 0.75
Non T lymphoid cells can express T cell surface characteristics: normal, HCL, and a range of leukemic B cells express T cell antigens after appropriate in vitro stimulation. Semin Oncol (1984) 0.75
An examination of the distribution of hen- and goose-type lysozymes in Anseriformes. Comp Biochem Physiol B (1976) 0.75
Local cellular immunity to the respiratory pathogen Bordetella pertussis: role of costimulatory molecules. Biochem Soc Trans (1997) 0.75
The sexual interaction of women with secondary orgasmic dysfunction and their partners. Arch Sex Behav (1984) 0.75
A megakaryocytic thrombocytopenia associated with the excess of Leu 2a+ suppressor cells. Scand J Haematol (1982) 0.75
Stimulated lymphoid cells of B lineage, but not plasma or myeloid cells, can express E receptor. Leuk Res (1985) 0.75